Tamoxifen [orch, phsu]
Plasma homocystine level [lbpr]
Health [idcn]
Women [popg]
treatment [ftcn]
Tamoxifen [orch, phsu]
Associated [qlco]
Reduced [qlco]
Incidence [qnco]
Myocardial Infarction [dsyn]
Plasma [bdsu]
homocysteine [aapp, bacs]
Independent [idcn]
Risk factor [qnco]
Cardiovascular disease [dsyn]
Study [mnob]
effects [qlco]
Tamoxifen [orch, phsu]
Plasma [bdsu]
homocysteine [aapp, bacs]
Health [idcn]
Women [popg]
Participating [ftcn]
italian [lang]
prevention trial [resa]
Breast Cancer [neop]
randomized [resa]
DOUBLE BLIND [resa]
placebo [topp]
Aged [orga]
Previous [tmco]
Hysterectomy [topp]
Non-Malignant [qlco]
condition [dsyn]
contraindications [qlco]
Tamoxifen [orch, phsu]
Plasma [bdsu]
Level [qlco]
homocysteine [aapp, bacs]
Measured [qlco]
Randomization [resa]
months [tmco]
Mean [qnco]
Plasma [bdsu]
Level [qlco]
homocysteine [aapp, bacs]
mU/L [qnco]
Mole [neop]
Tamoxifen [orch, phsu]
Group [idcn]
placebo [topp]
Group [idcn]
months [tmco]
P NOS [aapp, imft]
Between [spco]
Group [idcn]
Time [tmco]
High [qlco]
baseline [bodm]
homocysteine level [lbpr]
lowering [spco]
Effect [qlco]
Tamoxifen [orch, phsu]
statistically significant [qnco]
Effect [qlco]
Age [orga]
Body Mass Index [diap]
Smoking [inbe]
Habit [inbe]
baseline [bodm]
homocysteine levels [lbpr]
Variation [qlco]
Time [tmco]
Found [qnco]
Conclusion [idcn]
Tamoxifen [orch, phsu]
mg day [qnco]
months [tmco]
Decreased [qnco]
Plasma homocystine level [lbpr]
Health [idcn]
Women [popg]
This [euka]
Effect [qlco]
Contribute [acty]
Effect [qlco]
Myocardial Infarction [dsyn]
